Case report: Recovery from refractory myasthenic crisis to minimal symptom expression after add-on treatment with efgartigimod
Myasthenic crisis, a life-threatening exacerbation of myasthenia gravis, is a significant clinical challenge, particularly when refractory to standard therapies. Here, we described a case of myasthenic crisis in which the patient transitioned from refractory myasthenic crisis to minimal symptom expr...
Main Authors: | Keiko Watanabe, Shinichi Ohashi, Takuya Watanabe, Yuki Kakinuma, Ryuta Kinno |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1321058/full |
Similar Items
-
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series
by: Jie Song, et al.
Published: (2024-07-01) -
Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis
by: Jing Ma, et al.
Published: (2024-11-01) -
Case report: Successful perioperative intervention with efgartigimod in a patient in myasthenic crisis
by: Shahar Shelly
Published: (2025-01-01) -
Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neonatal intensive care unit
by: Fangyi Shi, et al.
Published: (2025-02-01) -
Efgartigimod combined with steroids as a fast-acting therapy for myasthenic crisis: a case report
by: Hiroya Ohara, et al.
Published: (2024-08-01)